Emergent BioSolutions Inc.
NYSEEmergent BioSolutions reports after the close today with nearly one-in-five free-float shares already borrowed against it — and a stock that has given up most of its modest month-long gains in a single week. Short interest is the defining story here. It has climbed to 18.5% of the free float, up 6.2% over the past month in share terms and ticking higher again on Wednesday to around…
Snapshot as of 8 May 2026
Emergent BioSolutions reports after the close today with nearly one-in-five free-float shares already borrowed against it — and a stock that has given up most of its modest month-long gains in a single week. Short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EBS — free to start on ORTEX.
Sign up for free →Open EBS on ORTEX